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neuroticism. The results of this pilot study suggest that
further work should examine the mediation of the genetic effects on personality traits by biochemical measures and their moderation by gender.

Abstract
A functional polymorphism in the regulatory region of
the serotonin transporter gene (5-HTTLPR) is considered to be a plausible candidate gene for anxiety-related
personality traits and for alcoholism. Empirical support
for the association between 5-HTTLPR and psychological traits has been somewhat inconsistent; however, observations of the functional dominance of the low-activity s-allele over the l-allele have been more consistent.
When studying the influence of particular genes on psychological traits, it seems useful also to assess more biological intermediate traits that may mediate the effects of those genes on the traits of interest. The present
study examined relationships between 5-HTTLPR genotype, whole blood serotonin (5-HT) level, and platelet
5-HT binding in 150 Caucasian subjects from 50 biological families. Individuals with the s-allele had lower average platelet 5-HT binding availability than those with
the l/l genotype (P < 0.025). Whole blood 5-HT level
was not associated with 5-HTTLPR genotype. In adult
men, those with the s-allele had higher mean scores on
the NEO-FFI personality trait of openness than did those
with the l/l genotype (P= 0.002). The effect was not statistically significant in women (P = 0.42), although it was
in the same direction. Our findings do not support an
association of 5-HTTLPR genotype with alcoholism diagnosis, alcoholism subtype, or the personality trait of

Keywords: association study, 5-HT, 5-HTTLPR, binding
availability, openness, neuroticism
Perhaps the most promising candidate gene in psychiatric genetics is a variant in the promoter region of the serotonin transporter, called 5-HTTLPR [Heils et al., 1996, 1997;
Lesch et al., 1996]. The two common alleles, short (s) and
long (1), have functional differences in lymphocytes [Lesch
et al., 1996], in blood platelets [Greenberg et al., 1999], and
in brain [Little et al., 1998]. 5-HTTLPR is considered to be
an important candidate to influence risk for psychiatric disorders [Stoltenberg and Burmeister, 2000], such as obsessive-compulsive disorder (OCD) [Hanna et al., 1998; Bengel
et al., 1999], affective disorders [Collier et al., 1996], autism
[Cook et al., 1997], and alcoholism [Sander et al., 1997; Edenberg et al., 1998; Hallikainen et al., 1999; Hammoumi et al.,
1999; Ishiguro et al., 1999].
Associations between 5-HTTLPR and normal variation in personality traits, especially those related to anxiety, have been widely studied [Lesch et al., 1996; Mazzanti
et al., 1998; Gustavsson et al., 1999; Greenberg et al., 2000].
The s-allele appears to be associated with higher scores on
anxiety-related measures in some populations [Greenberg
et al., 2000].
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The present pilot study examines associations between
5-HTTLPR and indexes of 5-HT function (whole blood 5HT [WB-5-HT] and platelet 5-HT transporter binding) in
families. In addition, associations between 5-HTTLPR genotype and personality traits measured by the NEO-Five
Factor Inventory (NEO-FFI) [Costa and McCrae, 1992] are
examined in adults. Finally, we compare allele frequencies
in adult males grouped by alcoholism diagnosis and by alcoholism subtype.
The Michigan-Michigan State Longitudinal Study
(MMSLS) [Zucker, 1987; Fitzgerald et al., 1995; Zucker et al.,
1996, 1997] is following a population-based sample of children of alcoholics, both biological parents, and an ecologically comparable but nonalcoholic group of control families at 3-year intervals (i.e., Waves), beginning when the
target boys were ages 3 to 5 and the target girls were between ages 3 and 11 [Zucker et al., 2000]. Alcoholism diagnosis was assessed using the Feighner diagnostic criteria
[Feighner et al., 1972] within a structured clinical interview
format [Robins et al., 1981].
Wave one involved 215 alcoholic and 96 nonalcoholic
control families of primarily lower to lower-middle socioeconomic class and all of non-Hispanic Caucasian background. Inclusion criteria for the larger study included
having a biological son between age 3 and 6 living in an intact family with both biological parents. Fetal alcohol syndrome in target children was exclusionary. Maternal alcoholism was neither inclusionary nor exclusionary for
alcoholic families, although a subset of women married
to antisocial alcoholic men (41%) met lifetime DSM-III-R
[American Psychiatric Association, 1987] alcohol abuse/
dependence diagnosis. Families were subtyped by paternal
alcoholism and antisocial personality disorder diagnoses
in earlier analytic work with the Longitudinal Study (antisocial alcoholism, nonantisocial alcoholism, nonalcoholic
control) [Wong et al., 1999; Poon et al., 2000].
Subjects in the present study were 161 Caucasian biological family members from 50 families drawn from the
MMSLS. These 50 families served as a pilot sample for initial examinations of biology and behavior relationships in
association to alcoholism with reports from the children
previously reported [Twitchell et al., 1998, 2000, 2001]. The
basic family structure includes a male target child (MTC)
and his biological father and mother (n = 30 families); some
also included a female target child (FTC; n = 14) and six
were missing data from one or more members.
Medication screening, collection of demographic data,
and blood sampling were performed by G.R.T. during an
in-home session. Twenty-one-gauge needles were used in
blood collection to ensure platelet integrity. Informed consent was obtained prior to data collection and the blood
draw. At that time, the children ranged in age from 7 to 15
(45 boys, 11.05 ± 1.82; 17 girls, 10.43 ± 2.50). This protocol
was approved by institutional review boards at the University of Michigan and Michigan State University. All subjects donated their blood samples and were paid for filling
out questionnaires. Samples assayed for whole blood serotonin (WB-5-HT) were immediately transported to the laboratory and stored at –70°C until the time of batch assay.
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Blood samples used for platelet 5-HTT binding availability
assay were immediately transported on ice to the laboratory for processing. Assays were performed blind to demographic and diagnostic information.
WB-5-HT assays and genotyping methods were described previously [Hanna et al., 1998]. WB-5-HT was analyzed by high-pressure liquid chromatography (HPLC)
with fluorometric detection [Anderson et al., 1981]. 5-hydroxytryptophan was used as an internal standard. Infraassay and interassay coefficients of variation were 0.8%
and 3.6%, respectively.
Oligonucleotide primers flanking the HTT polymorphic regulatory region (stpr5, 5′-GGCGTTGCCGCTCTGAATTGC;
stpr3,
5′-GAGGGACTGAGCTGGACAACCCAC) were used to generate a 484/528
bp fragment [Heils et al., 1996, 1997]. A second primer
(HTTp2A, 5′-TGAATGCCAGCACCTAACCC-3′; HTT-p2B,
5′-TTCTGGTGCCACCTAGACGC-3′) successfully amplified a 406/450 bp fragment from DNAs that failed to amplify with the first set. PCR was performed in a 10 μl volume containing approximately 50 ng of genomic template,
1 μM of each primer, 200 μM each dATP, dCTP, and dTTP,
100 μm each of dGTP, and 7′-deaza-dGTP, 0.6 units of Taq
polymerase (AmpliTaq; Perkin Elmer), 1.5 mM MgCl2, 5%
DMSO, 10 mM Tris-HCl, 50 mM KCl, and 0.001% gelatin.
Samples were processed in a Perkin Elmer GeneAmp PCR
System 9600 through 40 cycles of 30 sec at 95°C, 30 sec at
61°C, and 1 min at 72°C, followed by 10 min at 72°C. PCR
products were visualized on 4% agarose (Perkin Elmer)
gels containing 0.5 μg/mL ethidium bromide.
The methods used to assay [125I]RTI-55 (also referred to
as [125I]β-CIT) binding have been previously described [Little et al., 1993]. Briefly, the [125I]RTI-55 assay (specific activity 2,200 Ci/mmol; New England Nuclear/ Dupont) utilized a 0.32 M sucrose and 10 μM Na2HPO4 buffer at pH
7.4. A saturating concentration of [125I]RTI-55 (3 nM, approximately 8 × Kd previously determined, 0.37 nM) was
employed at equilibrium conditions (1.5 hr at 20°C). Incubations were performed with approximately 2 mg of pelleted platelets, followed by rapid filtration over Whatman
GF/B glass fiber filters presoaked in 0.01% polyethylenimine. Nonspecific binding was defined with 30 μM (-)cocaine. Specific binding averaged 90-95% of the total. Protein concentrations were determined using a commercial
assay kit (BioRad, Claremont, CA).
Personality characteristics in the adults were assessed
with the NEO-FFI [Costa and McCrae, 1992]. The NEO-FFI
consists of 60 items (12 items per factor) and is designed to
assess the five personality domains of neuroticism (negative
affect), extraversion (sociability, assertiveness), openness
(intellectual curiosity, unconventionality), agreeableness
(altruism, sympathy), and conscientiousness (self-discipline, deliberation). Internal consistency coefficients for the
NEO-FFI range from 0.68 to 0.86 for domain scales; validity
is well established [Costa and McCrae, 1992].
For association analysis of WB-5-HT level and of
[125I]RTI-55 binding, three models were tested: one additive
(s/s, s/l, l/l) and two dominance (sDom = s/s + l/s vs. l/
l, and lDom = s/s vs. l/s + l/l) using the ASSOC module of
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the Statistical Analysis for Genetic Epidemiology software
package [SAGE, 1998].
General linear models (SPSS) were used to assess associations between 5-HTTLPR genotype and NEO-FFI scores.
For fathers, we tested associations between 5-HTTLPR genotype, alcoholism diagnosis ,and sub-type (antisocial alcoholic [AAL], nonantisocial alcoholic [NAAL], or nonalcoholic [control]) [Zucker et al., 1996; Puttier et al., 1998] with
a case control design. Given the exploratory nature of these
analyses, we were more willing to commit type I than type
II errors; therefore, corrections for multiple testing were not
performed.
Eleven subjects were excluded from all analyses because
of medication use. Allele frequencies were calculated using
only parental genotypes. The frequency of the 5-HTTLPR
long allele l was 0.54 and the short allele s was 0.46 (n =
86). Genotypes were in Hardy-Weinberg equilibrium (chisquare = 0.24, 2 df, NS).
Overall mean WB-5-HT level was 188.08 ± 63.54 ng/
ml, (n = 150). [125I]RTI-55 binding was assayed for the final 54 samples collected. Mean [125I]RTI-55 binding level
was 147.96 ± 74.24 cpm/mg protein. Levels of WB-5-HT
and [125I]RTI-55 binding were not correlated in parents (r
= –0.01; P = 0.96; n = 33) or in children (r = –0.29; P = 0.20;
n= 21).
To control for age differences in WB-5-HT, we tested sex
differences separately among men and women and among
boys and girls. None were significant (all P values > 0.17);
therefore, we did not control for age or sex in the SAGE
analysis.
Model fit was assessed with the likelihood ratio statistic
that is distributed as chi-square with degrees of freedom being 1 less than the number of genotype groups (e.g., 2 for additive and 1 for dominance models). For WB-5-HT, including
marker data did not improve model fit, though the additive
model fit best (s/s = 208.43, l/s = 187.36, l/l =175.55; chisquare = 4.10; P> 0.10). Patterns of mean [125I]RTI-55 binding
levels were consistent with the dominance of the s-allele (s/
s = 138.50, l/s = 133.31, l/l = 190.15); accordingly, including
sDom marker data improved model fit (chi-square = 5.19; P
< 0.025). Neither the lDom nor the additive marker data improved model fit (i.e., P values > 0.05).

Table I presents the mean raw NEO-FFI adult personality scores by genotype. One-way ANOVAs were used
to test the effects of 5-HTTLPR on each of the personality
measures. Only mean openness scores were significantly
different for the genotype groups (S [s/s and 1/s] = 38.34,
L [l/l] = 34.54; F = 7.04; P = 0.01).
To examine the observed association further, we performed one-way ANOVAs separately for men and women.
Among men, mean openness scores were different for the
genotype groups (S = 38.25, L = 32.50; F = 10.60; P = 0.002);
among women, they were not (S = 38.43, L = 36.58; F = 0.68;
P = 0.42). The effect of 5-HTTLPR on openness appears to
be moderated by gender.
Father’s genotype was not related to his alcoholism subtype (Fisher exact statistic = 2.24; P = 0.73; Table II). Similarly, when the genotype frequencies of those with any
alcoholism diagnosis (AAL + NAAL) were compared to
nonalcoholic controls, no relationship was observed (chisquare = 1.50, 4 df, P > 0.75).
Patterns in binding availability of the 5-HTT in blood
platelets (indexed by [125I]RTI-55 binding) were consistent
with the dominance of the s-allele for lower function. Levels of 5-HTT binding in the L-group (l/l) were 42% higher
than in the S-group (l/s and s/s). This closely replicates the
difference observed in lymphocyte membrane preparations
reported by Lesch et al. [1996].
Levels of WB-5-HT were neither associated with 5-HTTLPR genotype nor correlated with platelet 5-HTT binding
availability. WB-5-HT content likely reflects a number of
different processes in addition to 5-HT uptake, so it is not
surprising that WB-5-HT content and [125I]RTI-55 binding
levels were not correlated. These results suggest that general statements about serotonergic dysfunction should be
made cautiously.
In this study, we observed a difference in mean neuroticism scores of approximately 1/10 of a point (L = 28.63, S =
28.74; n = 86). This is in contrast to the findings of Lesch et
al. [1996] and a large replication sample of mostly women
(primarily sibling pairs) collected by the same group that
found higher levels of neuroticism in individuals with the
s-allele [Greenberg et al., 2000]. Other studies have failed to
replicate the association [Flory et al., 1999; Jorm et al., 2000].

Table I. Mean NEO-FFI Personality Traits Scores and Standard Deviations for Groups Defined by 5-HTTLPR Genotype*
NEO-FFI scores by genotype
Genotype

l/l (group L)

Number per group
Neuroticism
Extraversion
Openness
Agreeableness
Conscientiousness

24
28.63 ±8.60
41.04 ±6.44
34.54 ±5.01
45.13 ±4.79
46.92 ±8.14

l/s

s/s

45
29.20 ±9.39
41.98 ±6.08
38.29 ±6.86
44.71 ±6.47
43.69 ±8.15

17
27.53 ±6.76
42.41 ±5.47
38.47 ±4.53
46.71 ±6.88
48.06 ±6.27

l/s & s/s (group S)

F

S–L

62				
28.74 ±8.73
0.003
0.11
42.10 ±5.88
0.59
1.06
38.34 ±6.27
7.04
3.80
45.26 ±6.59
0.008
0.13
44.89 ±7.88
1.13
-2.03

P
0.96
0.47
0.01
0.93
0.29

Pa
0.44
0.41
0.005
0.90
0.17

*Mean scores and standard deviations for the five major traits measured by the NEO-FFI stratified by genotype and group. F =
one-way ANOVA statistics; S – L = mean score for S-genotype group minus mean score for L-genotype group; P = two-tailed
significance.
a Two-tailed significance level after controlling for sex and father’s alcoholism status in a general linear model.
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Table II. Observed 5-HTTLPR Genotypes and Frequencies of
s-Allele for Fathers Categorized by Alcoholism Subtype*
AAL
NAAL
Control
Total

s/s

l/l

l/s

N

F(s)

4
4
2
10

10
6
6
22

3
4
5
12

17
16
13
44

0.53
0.50
0.38
0.48

*AAL = antisocial alcoholic; NAAL = nonantisocial alcoholic;
Control = nonalcoholic.
Father’s genotype is not associated with his alcoholism status
(Fisher exact statistic = 2.24; P = 0.73).

It may be that differences between the sample populations
can account for such inconsistencies. The sample analyzed
in the present study, while not a treatment population, its
diagnostic characteristics both for alcoholism and comorbid psychiatric disorders clearly establish it as a clinical one
[Zucker et al., 2000].
In this study, 5-HTTLPR genotype groups differed on
the personality trait of openness. The association was statistically significant only among men; although among
women, the pattern was in the same direction (i.e., higher
mean scores for individuals with an s-allele). Because
mean platelet 5-HTT binding availability was lower in individuals with an s-allele, these results suggest that the effect of 5-HTTLPR on openness may be partially mediated
through 5-HTT binding availability and moderated by gender. However, in the present study, we could not fully support this mediational hypothesis because the correlation
between [125I]RTI-55 binding and openness was not significant (n = 33; r = –0.18; P=0.31), but this may due to low
statistical power. Testing mediational hypotheses between
genes, biochemical, or physiological measures and behavior may prove to be an important approach to understanding heredity-behavior relations.
In the study by Greenberg et al. [2000], the pattern of
mean openness scores in their new sample is similar to the
one we report, although the differences were not statistically significant. This pattern is not seen in their combined
sample. The samples that Greenberg et al. [2000] added
are those reported by Lesch et al. [1996], who appear to be
younger, more ethnically diverse, better educated, and perhaps contain different distribution of sexual orientation
than our study population. It is possible that such differences account for the observed discrepancies.
Higher openness scores are related to a history of depression, and this effect is over and above the association
between neuroticism and depression [Wolfenstein and
Trull, 1997]. It may be that the s-allele increases risk for depression through either neuroticism or openness. That the
mean openness scores for those with s/s and l/s genotypes
are different from those with the VI genotype in the present study provides some measure of confidence because
it mirrors the pattern seen for [125I]RTI-55 binding. The P
value of the association of 5-HTTLPR genotype and openness when controlling for sex and father’s alcoholism status (P= 0.005) survives Bonferroni correction for the 10

comparisons conducted for genotype and NEO-FFI scores.
However, further confidence will require replication. Until
then, these findings should be regarded as preliminary and
interpreted with caution.
Father’s alcoholism diagnosis or alcoholism subtype was
not associated with 5-HTTLPR genotype. This is consistent
with findings from the COGA group [Edenberg et al., 1998].
However, other groups have reported associations between
5-HTTLPR and alcohol use disorders in other populations
(e.g., dependence in French [Hammoumi et al., 1999], antisocial alcoholism in Finnish [Hallikainen et al., 1999], and
early-onset alcoholism in Japanese [Ishiguro et al., 1999]).
Allelic variation at 5-HTTLPR has also been found associated with low response to alcohol [Schuckit et al., 1999] and
high ethanol tolerance [Turker et al., 1998]. Taken together,
these conflicting reports (and others) highlight the complexity inherent in the study of psychiatric genetics [Stoltenberg and Burmeister, 2000] and suggest that in different
environments and populations the pattern of 5-HTTLPR effects may be different. In other words, genotype × environment and/or genotype × genotype interactions may exist
for 5-HTTLPR effects on alcoholism.
In summary, this study replicated the dominance pattern of the s-allele for reduced 5-HTTLPR function as indexed by platelet [125I]RTI-55 binding. Results did not
support for the association of 5-HTTLPR genotype with
neuroticism or alcoholism; however, increased mean openness scores were associated with the s-allele.
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